Publications and related articles about us and the wound care industry

Piomic Medical Announces First Patients Enrolled in MAVERICKS Study Sites

03 Sep 2023

Trial seeks to assure Piomic’s COMS® treatment is safe and effective in therapy-refractory diabetic foot ulcers

Read more
Piomic Medical Announces First Patients Enrolled in MAVERICKS Study Sites
Piomic receives Medicare Category B Designation for MAVERICKS clinical trial

31 Aug 2023

CMS has approved the COMS One device for Category B designation and for Medicare coverage purposes during Piomic's IDE study

Read more
Piomic receives Medicare Category B Designation for MAVERICKS clinical trial
Piomic receives certification under MDR, the new European Medical Device Regulation

27 Apr 2023

Piomic Medical has received certificates according to MDR for its Class IIa and Class Is medical devices of the COMS® One Therapy System.

Read more
Piomic receives certification under MDR, the new European Medical Device Regulation
Bernard Laurel appointed as the President of Piomic Medical Inc.

10 Feb 2023

M&A experienced advanced wound care leader appointed as President of US Subsidiary Piomic Medical Inc.

Read more
Bernard Laurel appointed as the President of Piomic Medical Inc.
Piomic Medical receives unconditional FDA IDE approval for U.S. pivotal trial

01 Dec 2022

Piomic Medical receives unconditional IDE approval from the FDA for MAVERICKS, the pivotal study for the COMS® One Therapy System in patients with refractory diabetic foot ulcers.

Read more
Piomic Medical receives unconditional FDA IDE approval for U.S. pivotal trial
Bertrand Hughes appointed as the Chairman of the Board of Directors

05 Aug 2022

Highly experienced expert in advanced wound care appointed Chairman of the Board of Directors.

Read more
Bertrand Hughes appointed as the Chairman of the Board of Directors
Piomic Medical closes oversubscribed financing round to bring COMS® therapy into US patients’ homes

29 Jul 2022

Piomic Medical closes oversubscribed financing round to bring COMS® therapy into US patients’ homes

Read more
Piomic Medical closes oversubscribed financing round to bring COMS® therapy into US patients’ homes
Karina Candrian joins the Board of Directors

21 Jun 2022

As a serial MedTech entrepreneur, Karina Candrian has more than 20 years of practical experience in the healthcare industry and covers various functions along the entire value chain.

Read more
Karina Candrian joins the Board of Directors

Events calendar

Don't miss our updates!
You must complete your email.
You must accept our Privacy Policy